No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs530075993 |
chr15:93580677-93580678 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs77706755 |
chr15:93580702-93580703 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs78887276 |
chr15:93580709-93580710 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs532501435 |
chr15:93580713-93580714 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs147463877 |
chr15:93580747-93580748 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs571456946 |
chr15:93580775-93580776 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs370546049 |
chr15:93580814-93580815 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs72765692 |
chr15:93580842-93580843 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs550874100 |
chr15:93580851-93580852 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs567589388 |
chr15:93580874-93580875 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs73458330 |
chr15:93580915-93580916 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs552704806 |
chr15:93580941-93580942 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs57374349 |
chr15:93580973-93580974 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
14 |
rs529568000 |
chr15:93580974-93580975 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs547333142 |
chr15:93581061-93581062 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs373095134 |
chr15:93581072-93581073 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs558262748 |
chr15:93581095-93581096 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs575409123 |
chr15:93581097-93581098 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs544421523 |
chr15:93581098-93581099 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs554807233 |
chr15:93581150-93581151 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs575039193 |
chr15:93581155-93581156 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs116505211 |
chr15:93581169-93581170 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs148529432 |
chr15:93581170-93581171 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs142880501 |
chr15:93581173-93581174 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs546304773 |
chr15:93581180-93581181 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs191322198 |
chr15:93581205-93581206 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs551047750 |
chr15:93581220-93581221 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs530696585 |
chr15:93581268-93581269 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs569454964 |
chr15:93581300-93581301 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs58922063 |
chr15:93581342-93581343 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs61536221 |
chr15:93581398-93581399 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs372407410 |
chr15:93581404-93581405 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs377361481 |
chr15:93581448-93581449 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs141046531 |
chr15:93581449-93581450 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs183516425 |
chr15:93581485-93581486 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs538653688 |
chr15:93581495-93581496 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs536848349 |
chr15:93581553-93581554 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs558199551 |
chr15:93581605-93581606 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs370418158 |
chr15:93581606-93581607 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs374025587 |
chr15:93581612-93581613 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs548908493 |
chr15:93581631-93581632 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs538006905 |
chr15:93581644-93581645 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs117797867 |
chr15:93581663-93581664 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs7163551 |
chr15:93581688-93581689 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
45 |
rs554109077 |
chr15:93581727-93581728 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs76078137 |
chr15:93581729-93581730 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs117971331 |
chr15:93581743-93581744 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs35153742 |
chr15:93581754-93581755 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs577147679 |
chr15:93581757-93581758 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs546241704 |
chr15:93581770-93581771 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|